Exploratory biomarker analysis of ribociclib plus letrozole in recurrent low-grade serous carcinoma: A GOG-3026 correlative study.
Year: 2026
Type: article
Source: PubMed
Institutions: The University of Texas MD Anderson Cancer Center, Roswell Park Comprehensive Cancer Center, Mayo Clinic, Moffitt Cancer Center, Mount Sinai Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Oklahoma Cancer Specialists and Research Institute, Northside Hospital, The US Oncology Network, University of Cincinnati
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7233419449
